Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells

This publication has 20 references indexed in Scilit:

• Modulation of multidrug-resistant multiple myeloma by cyclosporin
  The Lancet, 1992
• New triazine derivatives as potent modulators of multidrug resistance
  Journal of Medicinal Chemistry, 1992
• Lowry's handbook of right-to-know emergency planning
  Journal of Hazardous Materials, 1992
• Synergistic Effect of Cyclosporin A and Verapamil in Overcoming Vincristine Resistance of Multidrug‐resistant Cultured Human Leukemia Cells
  Japanese Journal of Cancer Research, 1990
• Quantitative Determination of Factors Contributing to Doxorubicin Resistance in Multidrug-Resistant Cells
  JNCI Journal of the National Cancer Institute, 1989
• Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells
  Biochemical Pharmacology, 1989
• The reversal of doxorubicin resistance by verapamil is not due to an effect on calcium channels
  International Journal of Cancer, 1988
• D‐verapamil and L‐verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro
  International Journal of Cancer, 1988
• Cellular Pharmacology of Doxorubicin in Sensitive and Resistant Rat Glioblastoma Cells in Culture
  Oncology, 1986
• Differentiated Rat Glial Cell Strain in Tissue Culture
  Science, 1968